Opportunity Information: Apply for RFA AR 17 001
Apply for RFA AR 17 001
- The HHS-NIH11 in the health sector is offering a public funding opportunity titled "Centers of Research Translation (CORT) (P50)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846,.
- This funding opportunity was created on May 11, 2016 and posted on May 11, 2016.
- Applicants must submit their applications by Oct 11, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers of Research Translation (CORT) (P50) opportunity (RFA-AR-17-001) is a National Institutes of Health (NIH), Department of Health and Human Services funding announcement administered through NIAMS, aimed at building center-level, team-based translational research programs. The core idea is to support a coordinated group of investigators who can tackle a clearly defined, high-impact translational research challenge focused on a single disease or a set of closely related diseases or conditions that fall within the NIAMS mission area. Rather than funding isolated projects, the program is structured to push multiple disciplines to work together in a way that accelerates movement from mechanistic insight to practical outputs that matter for patients, such as therapeutic targets, diagnostics, preventive strategies, or other tangible deliverables.
The FOA allows two main structural approaches for a CORT. In the first approach, the center is organized around a disease-targeted translational theme that is pursued through multiple synergistic translational Research Projects, with Research Cores included as needed to support those projects. In the second approach, the center is organized around one critical disease-related translational research question pursued through a single, highly collaborative Research Project that is enabled by several highly interactive Research Cores. In that model, the cores are not just service units; their work is meant to be deeply integrated and coordinated over time as the main project develops and is implemented. In both formats, the emphasis is on synergy, integration, and a coherent scientific plan where the whole is more valuable than the sum of the individual parts.
A compliant CORT application must include at least three strong research components in total, made up of one or more translational Research Projects and one or more Research Cores. An Administrative Core is mandatory for every application, reflecting the expectation that these centers require purposeful governance, coordination, communication, and oversight to function as a true team-science enterprise. The announcement also makes clear that leadership across the research components should come from relevant, and when appropriate, different disciplines, and investigators may be located in different departments, divisions, or even different institutions. This is designed to encourage cross-cutting expertise (for example, combining clinical and basic science perspectives, or pairing disease biology with engineering, imaging, computational analysis, biostatistics, or other specialized capabilities) so the center can address translational bottlenecks that a single lab or department would struggle to solve.
In terms of anticipated impact, NIAMS frames CORTs as engines for generating new knowledge about human pathophysiology while simultaneously driving translation toward improved patient care. The expected outputs include identification of new therapeutic or diagnostic targets and development of more effective treatments, diagnostics, or prevention strategies. The emphasis on deliverables and improved understanding of human disease signals that the program is meant to bridge gaps between discovery and clinical utility, not simply advance basic science in parallel.
Administratively, this is a discretionary grant program under the Health activity category, listed under CFDA numbers 93.846 (and also referenced alongside 93.846 in the source data). Eligible applicants are broad and include many types of domestic organizations: state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding higher education institutions in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other applicants as allowed by the additional eligibility language referenced in the announcement. This wide eligibility aligns with the multidisciplinary, potentially multi-institutional structure the program encourages.
The FOA was posted on May 11, 2016, with an application closing date of October 11, 2016 (original and current closing dates are the same in the listing). The award ceiling is listed as $1,000,000, and NIAMS expected to make approximately 4 awards. Taken together, those figures suggest a relatively selective competition intended to fund a small number of well-integrated centers with strong translational focus and clear, coordinated plans for projects, cores, and administrative leadership.
Frequently Asked Questions (FAQs)
What is the Centers of Research Translation (CORT) (P50) opportunity?
The Centers of Research Translation (CORT) (P50) opportunity (RFA-AR-17-001) is an NIH funding announcement administered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). It is designed to build center-level, team-based translational research programs that bring together a coordinated group of investigators.
Which agency and institute administer this funding announcement?
This is a National Institutes of Health (NIH), Department of Health and Human Services funding announcement administered through NIAMS (the National Institute of Arthritis and Musculoskeletal and Skin Diseases).
What is the main purpose of a CORT award?
The purpose is to support integrated, team-science translational research focused on a clearly defined, high-impact translational challenge. The program emphasizes coordinated efforts that accelerate movement from mechanistic insights toward practical, patient-relevant outputs such as therapeutic targets, diagnostics, preventive strategies, or other tangible deliverables.
What kinds of research topics are in scope for this opportunity?
The translational research challenge must focus on a single disease or a set of closely related diseases or conditions that fall within the NIAMS mission area, as described in the opportunity.
How is CORT different from funding isolated research projects?
Rather than supporting standalone projects, CORT is structured around integrated, synergistic components that work together toward a coherent translational goal. The emphasis is on coordination across disciplines and components so that the overall center delivers more impact than the individual parts would on their own.
What are the two main structural approaches allowed for a CORT center?
The opportunity allows two approaches:
- Approach 1: A disease-targeted translational theme pursued through multiple synergistic translational Research Projects, supported by Research Cores as needed.
- Approach 2: One critical disease-related translational research question pursued through a single, highly collaborative Research Project enabled by several highly interactive Research Cores.
In the single-project model, what role do the Research Cores play?
In the single-project model, the Research Cores are intended to be highly interactive and deeply integrated with the main project over time. They are not described as simple service units; instead, their work is meant to be coordinated as the primary project develops and is implemented.
What components must a compliant CORT application include?
A compliant application must include at least three strong research components in total. These components are made up of one or more translational Research Projects and one or more Research Cores.
Is an Administrative Core required?
Yes. An Administrative Core is mandatory for every CORT application. This reflects the expectation that these centers require formal governance, coordination, communication, and oversight to operate effectively as a team-science program.
How many Research Projects and Research Cores are required?
The opportunity states that an application must include at least three strong research components total, composed of one or more translational Research Projects and one or more Research Cores, plus a required Administrative Core. The exact breakdown between projects and cores can vary as long as the minimum component expectations are met.
What does NIAMS emphasize about synergy and integration?
NIAMS emphasizes that the center must present a coherent scientific plan with meaningful integration across projects and cores. The center should be designed so that collaboration and coordination create added value beyond what separate, independent efforts would achieve.
Are multi-disciplinary teams expected?
Yes. The announcement highlights leadership across research components coming from relevant, and when appropriate, different disciplines. This is meant to encourage cross-cutting expertise to overcome translational bottlenecks.
Can investigators be from different departments or institutions?
Yes. Investigators may be located in different departments, divisions, or even different institutions. This supports the multi-disciplinary and potentially multi-institutional structure encouraged by the program.
What types of expertise does the opportunity suggest could be combined?
The description gives examples such as combining clinical and basic science perspectives, or pairing disease biology with engineering, imaging, computational analysis, biostatistics, or other specialized capabilities to address translational barriers.
What kinds of outcomes or deliverables are expected from CORT centers?
Expected outputs include generating new knowledge about human pathophysiology while driving translation toward improved patient care. The opportunity specifically points to identifying new therapeutic or diagnostic targets and developing more effective treatments, diagnostics, or prevention strategies.
Is this opportunity focused on basic science, translational work, or both?
It is framed as translational and is intended to bridge gaps between discovery and clinical utility. While mechanistic insight is part of the pathway, the program emphasizes translation to practical outputs that matter for patients rather than advancing basic science in isolation.
What is the funding activity category and program type?
The opportunity is described as a discretionary grant program under the Health activity category.
What CFDA number is associated with this opportunity?
The listing includes CFDA 93.846 (and references 93.846 alongside the source data).
Who is eligible to apply?
Eligibility is broad and includes many types of domestic organizations, including:
- State, county, and city or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Federally recognized Native American tribal governments
- Other tribal organizations
- Public housing authorities/Indian housing authorities
- Nonprofit organizations with or without 501(c)(3) status (excluding higher education institutions in those nonprofit categories)
- For-profit organizations other than small businesses
- Small businesses
- Other applicants as allowed by additional eligibility language referenced in the announcement
Does the opportunity allow for-profit organizations to apply?
Yes. The eligibility list includes for-profit organizations other than small businesses, as well as small businesses.
When was the FOA posted?
The funding opportunity announcement was posted on May 11, 2016.
What is the application due date?
The application closing date is October 11, 2016. The listing indicates the original and current closing dates are the same.
What is the award ceiling?
The award ceiling is listed as $1,000,000.
How many awards did NIAMS expect to make?
NIAMS expected to make approximately 4 awards.
What does the expected number of awards suggest about competitiveness?
With an expectation of approximately 4 awards and a strong emphasis on integration and translational deliverables, the opportunity appears designed to fund a small number of highly coordinated, center-level programs.
Browse more opportunities from the same category: Health
Next opportunity: Enhance the Ability of Emergency Medical Services (EMS) to transport patients with highly infectious diseases (HID)
Previous opportunity: From Association to Function in the Alzheimers Disease Post Genomics Era (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AR 17 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AR 17 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Tuberculosis Vaccine Design (R01) Apply for PAR 16 254 Funding Number: PAR 16 254 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Mississippi Delta Health Collaborative Apply for CDC RFA DP16 1612 Funding Number: CDC RFA DP16 1612 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $3,150,000 |
| Public Health Preparedness and Response (PHPR) Cooperative Agreement for All-Hazards Public Health Emergencies: Zika 2016 Apply for CDC RFA TP16 1602 Funding Number: CDC RFA TP16 1602 Agency: HHS-CDC-OPHPR Category: Health Funding Amount: $5,000,000 |
| Grants for Early Medical/Surgical Subspecialists' Transition to Aging Research (GEMSSTAR) (R03) Apply for RFA AG 17 012 Funding Number: RFA AG 17 012 Agency: HHS-NIH11 Category: Health Funding Amount: $75,000 |
| From Association to Function in the Alzheimers Disease Post Genomics Era (R01) Apply for RFA AG 17 010 Funding Number: RFA AG 17 010 Agency: HHS-NIH11 Category: Health Funding Amount: $350,000 |
| Establishment of Centers of Excellence in Refugee Health Apply for CDC RFA CK15 150302CONT16 Funding Number: CDC RFA CK15 150302CONT16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Learning Collaboratives for Advanced Business Acumen Skills Apply for HHS 2016 ACL CIP PPBA 0181 Funding Number: HHS 2016 ACL CIP PPBA 0181 Agency: HHS-ACL Category: Health Funding Amount: $500,000 |
| Creutzfeldt - Jakob Disease (CJD) Support, Education, and Awareness Projects as Apply for CDC RFA CK15 150402CONT16 Funding Number: CDC RFA CK15 150402CONT16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Environmental Sampling with NAU for High Consequence Pathogens Apply for CDC RFA CK16 1606 Funding Number: CDC RFA CK16 1606 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: $300,000 |
| Children’s Hospitals Graduate Medical Education (CHGME) Payment Program Apply for HRSA 17 006 Funding Number: HRSA 17 006 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Jurisdictional Approach to Curing Hepatitis C Among HIV/HCV Coinfected People of Color - Evaluation and Technical Assistance Center Apply for HRSA 16 188 Funding Number: HRSA 16 188 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Inclusion of Mobile/e-Consents for Alzheimer's Disease Research (Admin Supp) Apply for PA 16 259 Funding Number: PA 16 259 Agency: HHS-NIH11 Category: Health Funding Amount: $100,000 |
| Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color – Jurisdictional Sites Apply for HRSA 16 189 Funding Number: HRSA 16 189 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R01) Apply for PAR 16 265 Funding Number: PAR 16 265 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R34) Apply for PAR 16 264 Funding Number: PAR 16 264 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01) Apply for PAR 16 262 Funding Number: PAR 16 262 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities Outside the United States Apply for CDC RFA IP16 1603 Funding Number: CDC RFA IP16 1603 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $400,000 |
| NHLBI Career Transition Award for Intramural Fellows (K22) Apply for PAR 16 267 Funding Number: PAR 16 267 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization Apply for CDC RFA IP16 1606 Funding Number: CDC RFA IP16 1606 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $2,000,000 |
| Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States Apply for CDC RFA IP16 1604 Funding Number: CDC RFA IP16 1604 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AR 17 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
